Location History:
- Bothell, WA (US) (1999)
- Germantown, MD (US) (1997 - 2000)
Company Filing History:
Years Active: 1997-2000
Title: **Innovative Contributions of Steven Michael Frey in Bacterial Detection**
Introduction
Steven Michael Frey is a notable inventor based in Germantown, MD, with an impressive portfolio of nine patents. His research primarily focuses on enhancing methods for detecting enteric pathogens, specifically Shigella and Campylobacter bacteria. Through his innovative contributions, he aims to improve public health solutions by enabling better detection and potential vaccination strategies against these harmful bacteria.
Latest Patents
Frey's latest patents demonstrate a significant leap in the field of microbiology. One such patent focuses on "Methods for detecting Shigella bacteria or antibodies to Shigella." This invention outlines in vitro methods for inducing or enhancing the expression of enteric bacterial antigens and virulence factors, leading to the production of antigenically enhanced Shigella bacteria. This enhanced bacterium exhibits a higher level of immunogenic antigens compared to those grown in traditional media. Furthermore, a specific culture medium is identified to support optimal growth conditions for these bacteria.
Another innovative patent by Frey details "Methods for detecting Campylobacter bacteria or antibodies to Campylobacter." Similar to his Shigella patent, this invention enhances the detection capabilities of Campylobacter through antigenically improved bacteria. By using a modified culture medium, Frey has significantly advanced the methods for detecting antibodies in samples, further contributing to diagnostic capabilities in clinical settings.
Career Highlights
Steven Michael Frey's career is marked by his role at Antex Biologics, Inc., where he has made substantial contributions to the field of microbiological detection and vaccine development. His work reflects a commitment to advancing scientific understanding and practical applications in the detection of harmful pathogens.
Collaborations
Frey collaborates with esteemed colleagues, including John L. Pace and Richard Ives Walker. Their combined expertise fosters a productive environment that leads to meaningful innovations in the biotechnological space, particularly in the development of novel detection methods for pathogenic bacteria.
Conclusion
In conclusion, Steven Michael Frey's contributions to the field of microbiology, particularly in the detection of Shigella and Campylobacter bacteria, underscore his significance as an innovator. With nine patents to his name, his ongoing research at Antex Biologics, Inc. and collaboration with fellow scientists continue to influence public health strategies related to infectious diseases. Frey's work is a testament to the vital role of inventors in addressing public health challenges through innovative science.